Regencell Bioscience (RGC) Stock Price, News & Analysis

Company Overview

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Key Stats

• Today's Range: $25.41 to $31.53
• 50-Day Range: N/A
• 52-Week Range: $0.08 to $83.60
• Volume: 935,782 shs
• Average Volume: 14.78 million shs
• Market Capitalization: $13.43 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RGC Stock Analysis - Frequently Asked Questions

How have RGC shares performed this year?

Regencell Bioscience's stock was trading at $63.35 at the beginning of the year. Since then, RGC stock has decreased by 56.6% and is now trading at $27.49.
View the best growth stocks for 2025 here.

When did Regencell Bioscience's stock split?

Regencell Bioscience's stock split before market open on Monday, June 16th 2025. The 38-1 split was announced on Monday, June 2nd 2025. The newly minted shares were distributed to shareholders after the market closes on Sunday, June 15th 2025. An investor that had 100 shares of stock prior to the split would have 3,800 shares after the split.

When did Regencell Bioscience IPO?

Regencell Bioscience (RGC) raised $22 million in an IPO on Friday, July 16th 2021. The company issued 2,300,000 shares at $8.50-$10.50 per share.

How do I buy shares of Regencell Bioscience?

Shares of RGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/23/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:RGC
• Previous Symbol: NASDAQ:RGC
• CIK: 1829667
• Web: N/A
• Phone: 852 2155 0823
• Fax: 852-2155-0853
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.02 per share
• Price / Book: 1,900.50

Miscellaneous

• Outstanding Shares: 494,490,000
• Free Float: N/A
• Market Cap: $18.80 billion
• Optionable: N/A
• Beta: 2.45